JPS6332781B2 - - Google Patents
Info
- Publication number
- JPS6332781B2 JPS6332781B2 JP61284880A JP28488086A JPS6332781B2 JP S6332781 B2 JPS6332781 B2 JP S6332781B2 JP 61284880 A JP61284880 A JP 61284880A JP 28488086 A JP28488086 A JP 28488086A JP S6332781 B2 JPS6332781 B2 JP S6332781B2
- Authority
- JP
- Japan
- Prior art keywords
- arginine
- crystals
- malic acid
- neutral salt
- neutral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 42
- 239000013078 crystal Substances 0.000 claims description 42
- 230000007935 neutral effect Effects 0.000 claims description 33
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 31
- 229930064664 L-arginine Natural products 0.000 claims description 31
- 235000014852 L-arginine Nutrition 0.000 claims description 31
- 150000003839 salts Chemical class 0.000 claims description 25
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 21
- 229940116298 l- malic acid Drugs 0.000 claims description 18
- 235000011090 malic acid Nutrition 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 11
- 238000002425 crystallisation Methods 0.000 claims description 8
- 230000008025 crystallization Effects 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 5
- -1 L-arginine L-malate anhydride Chemical class 0.000 claims description 3
- 239000003125 aqueous solvent Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- 239000007864 aqueous solution Substances 0.000 description 11
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010020575 Hyperammonaemia Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 238000004455 differential thermal analysis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 150000008535 L-arginines Chemical class 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28488086A JPS62142150A (ja) | 1986-11-28 | 1986-11-28 | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28488086A JPS62142150A (ja) | 1986-11-28 | 1986-11-28 | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4237879A Division JPS55136254A (en) | 1978-11-20 | 1979-04-06 | Basic l-amino acid l-malic acid salt crystal and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62142150A JPS62142150A (ja) | 1987-06-25 |
| JPS6332781B2 true JPS6332781B2 (pt) | 1988-07-01 |
Family
ID=17684231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28488086A Granted JPS62142150A (ja) | 1986-11-28 | 1986-11-28 | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62142150A (pt) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS536204A (en) * | 1976-07-08 | 1978-01-20 | Kubota Ltd | Scum removing apparatus |
-
1986
- 1986-11-28 JP JP28488086A patent/JPS62142150A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS536204A (en) * | 1976-07-08 | 1978-01-20 | Kubota Ltd | Scum removing apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62142150A (ja) | 1987-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4420432A (en) | Crystalline salt of basic L-amino acid with L-malic acid and process for the preparation thereof | |
| US20040062844A1 (en) | Salts of L-amino acids having improved taste and their preparation | |
| US4228099A (en) | Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders | |
| US20070004805A1 (en) | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate | |
| US6172111B1 (en) | Creatine pyruvates and a method of producing them | |
| EP2107053A1 (en) | Hydrate crystals of (2R,4R)-Monatin monosodium salt | |
| CN112125899B (zh) | 吡咯并喹啉醌二钠盐结晶、其制备方法及包含其的组合物 | |
| WO2008083226A2 (en) | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate | |
| JP2017526699A (ja) | （６ｓ）−５−メチルテトラヒドロ葉酸又はその塩の組成物及びその調製と応用 | |
| JP4796493B2 (ja) | Ｌ−リジン・クエン酸塩結晶 | |
| TWI279230B (en) | Pregabalin composition | |
| CN113956250A (zh) | 盐酸小檗碱药物共晶及其制备方法和用途 | |
| US4789666A (en) | Cytidine-diphosphocholine salts, particularly suitable for oral use | |
| JPS6332781B2 (pt) | ||
| JP7144320B2 (ja) | ３－ヒドロキシイソ吉草酸アミノ酸塩の結晶及びその製造方法 | |
| JPS6328419B2 (pt) | ||
| US7109373B2 (en) | Creatine salts and method of making same | |
| KR20040104020A (ko) | 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제 | |
| JPH0543590A (ja) | 結晶ラクチユロース三水和物とその製造法 | |
| US7301051B2 (en) | Creatine salts and method of making same | |
| JPS5865214A (ja) | Ｎ−アシル−ｌ−アスパルチルタウリンを含有する医薬 | |
| JP2001517227A (ja) | Ｌ−カルニチンもしくはアルカノイル−ｌ−カルニチンと２−アミノエタンスルホン酸との非吸湿性塩を含有する経口投与に適した固体状組成物 | |
| AU2012201606A1 (en) | Crystalline levofolinic acid and process for its preparation | |
| JP2002363173A (ja) | アセスルファム塩、その製造及び使用法 | |
| JP7425482B2 (ja) | イソキノリンスルホンアミドの新規な形態 |